Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
Completed
NCT Number: NCT02160925
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
The objective of this study is to investigate the utility of 99mTc-sestamibi SPECT/CT imaging for the diagnosis of renal oncocytomas.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Presence of a solid enhancing cT1 renal mass detected on cross-sectional imaging
- Scheduled to undergo surgery with either partial or radical nephrectomy
- Age ≥18 years
Exclusion criteria
- Pregnancy
- Evidence of nodal or distant metastases
- History of other malignancy with concern for renal metastasis
- Known allergy to technetium or sestamibi
Treatment and study plan
Preoperative 99mTc-Sestamibi SPECT/CT
OtherPrimary outcomes
-
Correlation of preoperative 99mTc-sestamibi SPECT/CT findings with tumor histology following surgical resection.
Time frame: Within 2 weeks of surgery
Sponsors and collaborators
Lead sponsor
Johns Hopkins University
Other
Registry information
Important dates
- Study start
- 2014
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Jun 11, 2014
- Registry last updated
- Jul 30, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.